Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline versus albumin priming to prevent intradialytic hypotension in acute kidney injury
RBR-9m634y8Phase 2Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Botucatu
- Start
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute kidney failure (AKF) comparing Control: 0.9% sodium chloride priming with Intervention: 20% albumin priming (2 arms). Primary endpoints: Prevention of blood pressure drop during hemodialysis and Prevention of hemodynamic instability during prolonged hemodialysis. Started Apr 2025; status: recruiting.
02
Drugs
albumin (human)sodium chloride
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on RBR-9m634y8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9m634y8.